JP2022527267A5 - - Google Patents
Info
- Publication number
- JP2022527267A5 JP2022527267A5 JP2021557228A JP2021557228A JP2022527267A5 JP 2022527267 A5 JP2022527267 A5 JP 2022527267A5 JP 2021557228 A JP2021557228 A JP 2021557228A JP 2021557228 A JP2021557228 A JP 2021557228A JP 2022527267 A5 JP2022527267 A5 JP 2022527267A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025006913A JP2025062611A (ja) | 2019-03-25 | 2025-01-17 | Ｔ細胞受容体及びその使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962823487P | 2019-03-25 | 2019-03-25 | |
| US62/823,487 | 2019-03-25 | ||
| PCT/IB2020/052776 WO2020194195A1 (en) | 2019-03-25 | 2020-03-24 | T cell receptors and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025006913A Division JP2025062611A (ja) | 2019-03-25 | 2025-01-17 | Ｔ細胞受容体及びその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022527267A JP2022527267A (ja) | 2022-06-01 |
| JPWO2020194195A5 JPWO2020194195A5 (https=) | 2023-03-17 |
| JP2022527267A5 true JP2022527267A5 (https=) | 2023-03-17 |
Family
ID=72611623
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557228A Withdrawn JP2022527267A (ja) | 2019-03-25 | 2020-03-24 | Ｔ細胞受容体及びその使用方法 |
| JP2025006913A Pending JP2025062611A (ja) | 2019-03-25 | 2025-01-17 | Ｔ細胞受容体及びその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025006913A Pending JP2025062611A (ja) | 2019-03-25 | 2025-01-17 | Ｔ細胞受容体及びその使用方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12577287B2 (https=) |
| EP (1) | EP3947688A4 (https=) |
| JP (2) | JP2022527267A (https=) |
| KR (1) | KR20210144782A (https=) |
| CN (1) | CN113795586B (https=) |
| AU (1) | AU2020245270A1 (https=) |
| BR (1) | BR112021018734A2 (https=) |
| CA (1) | CA3133945A1 (https=) |
| IL (1) | IL286620A (https=) |
| MX (1) | MX2021011462A (https=) |
| SG (1) | SG11202109701SA (https=) |
| TW (1) | TW202102533A (https=) |
| WO (1) | WO2020194195A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110950949B (zh) * | 2018-09-26 | 2022-04-05 | 香雪生命科学技术（广东）有限公司 | 一种识别ssx2抗原的t细胞受体 |
| JP7748284B2 (ja) | 2019-03-04 | 2025-10-02 | ユニバーシティー ヘルス ネットワーク | Ｔ細胞受容体及びその使用方法 |
| MX2021010541A (es) | 2019-03-04 | 2021-12-15 | Univ Health Network | Receptores de linfocitos t y metodos de uso de estos. |
| CN113795586B (zh) | 2019-03-25 | 2026-03-27 | 大学健康网络 | T细胞受体及其使用方法 |
| CN112442119B (zh) * | 2019-09-05 | 2023-02-24 | 香雪生命科学技术（广东）有限公司 | 一种识别ssx2的高亲和力t细胞受体 |
| IL312744A (en) * | 2021-11-10 | 2024-07-01 | Tscan Therapeutics Inc | MAGEA1 immunogenic peptides, binding proteins that recognize MAGEA1 immunogenic peptides and uses thereof |
| CN116063457A (zh) * | 2022-04-27 | 2023-05-05 | 恒瑞源正(广州)生物科技有限公司 | Mage-a1特异性t细胞受体及其用途 |
| CN116813744B (zh) * | 2023-02-23 | 2024-02-23 | 暨南大学 | 一种识别mage-a3抗原短肽的t细胞受体及其应用 |
| TW202523702A (zh) * | 2023-10-27 | 2025-06-16 | 美商帝斯肯醫療公司 | Magea1免疫原性肽、識別magea1免疫原性肽之結合蛋白及其用途 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1064022A4 (en) | 1998-03-13 | 2004-09-29 | Epimmune Inc | HLA BINDING PROTEINS AND THEIR USE |
| ATE395930T1 (de) | 1999-10-22 | 2008-06-15 | Aventis Pasteur | Verfahren zur erregung und/oder verstärkung der immunantwort gegen tumorantigene |
| US6506875B1 (en) | 2000-09-26 | 2003-01-14 | Ludwig Institute For Cancer Research | Isolated peptides which bind to HLA-C molecules and uses thereof |
| CA2682093A1 (en) * | 2007-03-29 | 2008-10-09 | Technion Research & Development Foundation Ltd. | Antibodies, methods and kits for diagnosing and treating melanoma |
| US9051391B2 (en) * | 2007-06-11 | 2015-06-09 | Takara Bio Inc. | Method for expression of specific gene |
| WO2010037395A2 (en) * | 2008-10-01 | 2010-04-08 | Dako Denmark A/S | Mhc multimers in cancer vaccines and immune monitoring |
| CN102272153B (zh) | 2008-11-24 | 2015-04-15 | 德国慕尼黑亥姆霍兹研究中心健康和环境有限公司 | 高亲和力t细胞受体及其应用 |
| WO2010088160A1 (en) | 2009-01-28 | 2010-08-05 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | T cell receptors and related materials and methods of use |
| PT2413956T (pt) * | 2009-04-02 | 2016-12-30 | Vaxon Biotech | Identificação, optimização e utilização de epitopos crípticos hla-a24 para imunoterapia |
| WO2011140284A2 (en) | 2010-05-04 | 2011-11-10 | Fred Hutchinson Cancer Research Center | Conditional superagonist ctl ligands for the promotion of tumor-specific ctl responses |
| ES2635335T3 (es) | 2010-09-20 | 2017-10-03 | Biontech Cell & Gene Therapies Gmbh | Receptores de células T específicos de antígeno y epítopos de células T |
| PH12013501201A1 (en) | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| WO2014207708A2 (en) | 2013-06-28 | 2014-12-31 | Auckland Uniservices Limited | Amino acid and peptide conjugates and conjugation process |
| KR101503341B1 (ko) | 2014-03-12 | 2015-03-18 | 국립암센터 | 자가암항원 특이적 cd8+ t 세포의 분리 및 증식방법 |
| AU2015343013B2 (en) | 2014-11-05 | 2020-07-16 | Board Of Regents, The University Of Texas System | Gene modified immune effector cells and engineered cells for expansion of immune effector cells |
| NL2014935B1 (en) | 2015-06-08 | 2017-02-03 | Applied Immune Tech Ltd | T cell receptor like antibodies having fine specificity. |
| WO2017120428A2 (en) | 2016-01-06 | 2017-07-13 | Health Research, Inc. | Compositions and libraries comprising recombinant t-cell receptors and methods of using recombinant t-cell receptors |
| JP6692040B2 (ja) | 2016-11-01 | 2020-05-13 | 学校法人自治医科大学 | 成人ｔ細胞性白血病を含むｈｔｌｖ−１ウイルス感染に対する腫瘍抗原特異的ｔ細胞 |
| JP7748284B2 (ja) | 2019-03-04 | 2025-10-02 | ユニバーシティー ヘルス ネットワーク | Ｔ細胞受容体及びその使用方法 |
| EP3935171A4 (en) | 2019-03-04 | 2022-12-28 | University Health Network | T-CELL RECEPTORS AND METHODS OF USE THEREOF |
| CN113795585B (zh) | 2019-03-04 | 2026-03-06 | 大学健康网络 | T细胞受体及其使用方法 |
| WO2020178738A1 (en) | 2019-03-04 | 2020-09-10 | University Health Network | T cell receptors and methods of use thereof |
| AU2020231927A1 (en) | 2019-03-04 | 2021-09-30 | University Health Network | T cell receptors and methods of use thereof |
| MX2021010541A (es) | 2019-03-04 | 2021-12-15 | Univ Health Network | Receptores de linfocitos t y metodos de uso de estos. |
| CN113795586B (zh) | 2019-03-25 | 2026-03-27 | 大学健康网络 | T细胞受体及其使用方法 |
-
2020
- 2020-03-24 CN CN202080031056.7A patent/CN113795586B/zh active Active
- 2020-03-24 CA CA3133945A patent/CA3133945A1/en active Pending
- 2020-03-24 AU AU2020245270A patent/AU2020245270A1/en active Pending
- 2020-03-24 BR BR112021018734A patent/BR112021018734A2/pt unknown
- 2020-03-24 SG SG11202109701S patent/SG11202109701SA/en unknown
- 2020-03-24 EP EP20776939.9A patent/EP3947688A4/en active Pending
- 2020-03-24 WO PCT/IB2020/052776 patent/WO2020194195A1/en not_active Ceased
- 2020-03-24 US US17/598,763 patent/US12577287B2/en active Active
- 2020-03-24 KR KR1020217033984A patent/KR20210144782A/ko not_active Ceased
- 2020-03-24 JP JP2021557228A patent/JP2022527267A/ja not_active Withdrawn
- 2020-03-24 MX MX2021011462A patent/MX2021011462A/es unknown
- 2020-03-25 TW TW109110020A patent/TW202102533A/zh unknown
-
2021
- 2021-09-23 IL IL286620A patent/IL286620A/en unknown
-
2025
- 2025-01-17 JP JP2025006913A patent/JP2025062611A/ja active Pending